We use cookies to understand how you use our site and to improve your experience. This includes personalizing content and advertising. To learn more, click here. By continuing to use our site, you accept our use of cookies. Cookie Policy.

Features Partner Sites Information LinkXpress hp
Sign In
Advertise with Us
LGC Clinical Diagnostics

Download Mobile App




Measles Virus Infection Impacts Immune Cells

By LabMedica International staff writers
Posted on 26 Nov 2019
Print article
Image: Colored scanning electron micrograph (SEM) of a B lymphocyte white blood cell (Photo courtesy of the US National Institute of Allergy and Infectious Diseases)
Image: Colored scanning electron micrograph (SEM) of a B lymphocyte white blood cell (Photo courtesy of the US National Institute of Allergy and Infectious Diseases)
Measles is a disease caused by the highly infectious measles virus (MeV) that results in both viremia and lymphopenia. Measles virus is a highly infectious lymphotropic virus associated with an extended period of immunosuppression after resolution of acute viremia.

Lymphocyte counts recover shortly after the disappearance of measles-associated rash, but immunosuppression can persist for months to years after infection, resulting in increased incidence of secondary infections. Memory B cell clones present before infection are depleted in post-measles samples even after lymphocyte counts had recovered, a change not seen in controls given an influenza vaccination.

An international team of scientists led by the Wellcome Sanger Institute (Cambridge, UK) used targeted sequencing to follow blood samples from more than two-dozen children prior to measles infections and again more than a month after the infections cleared. The sequence data pointed to decline in immune memory cells and B lymphocyte white blood cell diversity following measles infections.

In an effort to untangle the specific immune cell changes involved in the process, the team did isotype-resolved B-cell receptor sequencing to barcode and follow immune cells in peripheral blood samples collected at baseline in 26 unvaccinated children from a study in the Netherlands, and again some 40 to 50 days after their measles virus infections. Using B cell receptor (BCR) sequencing of human peripheral blood lymphocytes, the team extrapolated antibody; naïve B cell and memory B lymphocyte profiles; and other immune patterns, comparing them with those in samples from unvaccinated children who dodged measles infections and with samples from adults who received a trivalent inactivated influenza vaccine.

The investigators identified two immunological consequences from measles underlying immunosuppression: (i) incomplete reconstitution of the naïve B cell pool leading to immunological immaturity and (ii) compromised immune memory to previously encountered pathogens due to depletion of previously expanded B memory clones. The team saw decreased antibody levels and poorer B memory immune cell responses to the influenza H1N1 virus in influenza vaccinated ferrets that had been through a measles-like canine distemper virus infection than in the animals that remained canine distemper virus-free.

The authors concluded that their results show that MeV infection causes changes in naïve and memory B lymphocyte diversity that persist after the resolution of clinical disease and thus contribute to compromised immunity to previous infections or vaccinations. This work highlights the importance of MeV vaccination not only for the control of measles but also for the maintenance of herd immunity to other pathogens, which can be compromised after MeV infection. The study was published on November 1, 2019 in the journal Science Immunology.

Related Links:
Wellcome Sanger Institute


Gold Member
Troponin T QC
Troponin T Quality Control
Verification Panels for Assay Development & QC
Seroconversion Panels
New
Chlamydia Trachomatis Assay
Chlamydia Trachomatis IgG
New
Unstirred Waterbath
HumAqua 5

Print article

Channels

Clinical Chemistry

view channel
Image: The GlycoLocate platform uses multi-omics and advanced computational biology algorithms to diagnose early-stage cancers (Photo courtesy of AOA Dx)

AI-Powered Blood Test Accurately Detects Ovarian Cancer

Ovarian cancer ranks as the fifth leading cause of cancer-related deaths in women, largely due to late-stage diagnoses. Although over 90% of women exhibit symptoms in Stage I, only 20% are diagnosed in... Read more

Molecular Diagnostics

view channel
Image: The breakthrough could result in a higher success rate using a simple oral swab test before IVF (Photo courtesy of Shutterstock)

POC Oral Swab Test to Increase Chances of Pregnancy in IVF

Approximately 15% of couples of reproductive age experience involuntary childlessness. A significant reason for this is the growing trend of delaying family planning, a global shift that is expected to... Read more

Technology

view channel
Image: The new algorithms can help predict which patients have undiagnosed cancer (Photo courtesy of Adobe Stock)

Advanced Predictive Algorithms Identify Patients Having Undiagnosed Cancer

Two newly developed advanced predictive algorithms leverage a person’s health conditions and basic blood test results to accurately predict the likelihood of having an undiagnosed cancer, including ch... Read more
Copyright © 2000-2025 Globetech Media. All rights reserved.